The global animal model market is estimated to garner a revenue of around US$ 1,943.3 million in 2024. Animals possess a shorter life cycle, a high genotype resemblance, and are easy to test in laboratories.
As per the animal model demand analysis report, the overall market is predicted to grow at a moderate CAGR of 6% over the next ten years. The report also forecasts the global animal model industry to reach a value of nearly US$ 3,476.8 million by the end of this forecast period.
Animal Model Market Trends and Analysis
| Report Attribute | Details |
|---|---|
| Animal Model Market Revenue (2024) | US$ 1,943.3 million |
| Market Anticipated Forecast Value (2034) | US$ 3,476.8 million |
| Market Projected Growth Rate (2024 to 2034) | 6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In 2019, the net revenue generated by animal model suppliers and service providers was assessed to be around US$ 1,425 million. The global animal model market witnessed a growth rate of 6.4% from 2019 to 2023.
During this period, the animal model market had been facing tremendous pressure from animal welfare organizations and activists in various countries. However, the situation has changed drastically since the outbreak of COVID-19. This change in situation was due to animal model testing being central in research towards developing an effective vaccine against novel coronavirus or other pathogens.
| Historical Market CAGR (2019 to 2023) | 6.4% |
|---|---|
| Forecasted Market CAGR (2024 to 2034) | 6% |
The industry also received a significant fillip during this period due to a rapid rise in demand for non-human primates for research into COVID-19 vaccines. This research is expected to continue in the near future, driving the demand for different species for preclinical models.
Alternatives such as cell cultures, tissue cultures, and computer models are also available. However, animal models are preferred owing to the complexity of the living systems. Significant incidence rates of diseases, along with adverse effects of drugs, have driven the adoption of animal models to ensure the safety of humans. So, the persisting demand for laboratory animals in pharmacological studies is expected to strengthen the market with the expansion of the pharmaceutical sector.
Pharmacological studies, which include target identification & validation, toxicology drug screening & lead optimization & safety screening, have also surged the demand for advanced animal models for preclinical research. For instance, according to the Pharmaceutical Research and Manufacturers of America, biopharmaceutical businesses spent roughly US$ 79.6 billion on research and development in the United States in 2018.
Government intervention in academic and research institutions is increasing for the development of standard protocols related to animal models. Researchers utilize animal models for basic research, such as developing new therapeutic strategies to treat human diseases and preclinical analyses of developed drug safety & efficacy. Moreover, continued advances in animal models, the availability of modern healthcare systems, and a considerable increase in demand for modern healthcare facilities are also expected to propel the market to some degree.
One of the major restraints in the adoption of some animal models is the risk of researchers using animal models being susceptible to false analogy, where implications built around assumptions of similarities between animals and humans can potentially lead to an incorrect conclusion.
Principal Consultant
The comparative analysis and market growth rate of adjacent markets reveal a clear picture of the future growth prospects for the market under discussion. The animal healthcare industry is subject to product development activities under the Animal Rule and growing demand for chronic disease therapeutics. On the other hand, the growth of the animal artificial insemination market is anticipated to strengthen the supply chains for animal model suppliers in the coming days.
Animal Model Market:
| Attributes | Animal Model Market |
|---|---|
| CAGR (2024 to 2034) | 6% |
| Growth Factor | Significant investments are being made in animal model research in the post-pandemic period. |
| Market Opportunities | Increasing government intervention in research institutes to develop standard protocols associated with animal models. |
| Market Challenges | The cost of animal research is high and results in delays in drug approvals that impact the demand for animal models. |
Animal Healthcare Market:
| Attributes | Animal Healthcare Market |
|---|---|
| CAGR (2024 to 2034) | 4.3% |
| Growth Factor | The rising prevalence of foodborne and zoonotic diseases in livestock has increased the importance of animal healthcare products. |
| Market Opportunities | Introduction of wearables, smart tags, sound-detecting devices, and predictive software for animal health monitoring. |
| Market Challenges | Absence of vaccinations against many animal diseases and stringent regulatory clearance procedures required to commercialize them. |
Animal Artificial Insemination Market:
| Attributes | Animal Artificial Insemination Market |
|---|---|
| CAGR (2024 to 2034) | 6% |
| Growth Factor | The rise in meat consumption in the developed countries and the demand for improving food security in low-income group countries. |
| Market Opportunities | In collaboration with public organizations, government organizations are encouraging mass animal artificial insemination programs. |
| Market Challenges | Limited awareness among small farmers about the advantages of artificial insemination techniques. |
The table below puts together the CAGRs for a few countries expected to witness a notable increment in their share of the animal model industry. In North American and European countries witness robust growth rates with relevant policies being reformed by the government to spur funding plans related to animal model research. Several animal model solution providers in Asia are also expected to make huge investments in biogenic research which is reflected in the promising growth rates of China and Japan.
| Regional Market Comparison | CAGR (2024 to 2034) |
|---|---|
| United States | 6.7% |
| Germany | 8.2% |
| United Kingdom | 6.6% |
| Japan | 4.7% |
| China | 6.1% |
The demand for experimental animals in the United States for in vivo models is predicted to increase 6.7% through the projected years. The United States is likely to be a dominating country in the animal model market because of
The market in China holds a significant share of the global market and is likely to maintain its dominance in Asia for laboratory animals for pharmacological studies. Some prominent factors that are expected to drive the China market at 6.1% CAGR through the forecast period include:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Based on species, revenue from rat-based animal models is estimated to account for a 37.3% market share in 2024.
| Attributes | Details |
|---|---|
| Top Species Type or Segment | Rats |
| Market Share in 2024 | 37.3% |
Revenue from the use of rats in animal models is also slated to expand through the forecasted years due to the following reasons:
The development of animal models for drug discovery is expected to account for nearly 54.4% of the market share in 2024.
| Attributes | Details |
|---|---|
| Top Application Type | Drug Discovery and Development |
| Market Share in 2024 | 54.4% |
A few key factors that are expected to retain the dominance of the drug discovery and development segment through the forecast years include:
Key animal model system providers are focusing on strategic acquisitions, mergers, collaborations, and partnerships to grow their client base and boost their industrial position. Recent investments by leading companies have created prospects for the market to expand globally.
The market is now highly influenced by technological interventions in software modeling for time and cost efficiency, along with the growing ethical concerns in reducing the number of live animals used for research. Recent key developments in the market include the development of a novel monkey research model using CRISPR technology.
Recent Developments in the Global Animal Model Market
In January 2020, Horizon Discovery Group plc. confirmed a partnership and license deal with Mammoth Biosciences to gain access to Mammoth's unique CRISPR technology. The partnership is expected to make it easier for Horizon to provide a new generation of genetically altered CHO cells to manufacture biotherapeutics such as therapeutic antibodies.
In March 2022, Charles River Laboratories and Hera Biolabs inked a contract for the breeding, marketing, and sales of SRG rats to the world's preclinical research community. Through this deliberate partnership, Hera BioLabs is aiming to expand the geographic reach of its highly immunodeficient rat model.
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | US$ 1,943.3 million |
| Projected Market Size (2034) | US$ 3,476.8 million |
| Anticipated Growth Rate (2024 to 2034) | 6% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ million or billion for Value and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa |
| Key Segments Covered | By Species Type, By Application, By End User, and By Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global animal model market is estimated to be valued at US$ 1,943.3 million in 2024.
The global animal model market is to grow at 6% during the forecast period.
The global animal model market is predicted to be valued at US$ 3,476.8 million by 2034.
The United States accounts for over one-fourth revenue share of the global market.
Germany is predicted to witness an 8.2% CAGR in the adoption of animal models through 2034.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Species 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Species, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Species, 2024 to 2034 5.3.1. Rats 5.3.2. Mice 5.3.3. Guinea Pigs 5.3.4. Rabbits 5.3.5. Monkeys 5.3.6. Dogs 5.3.7. Pigs 5.3.8. Cats 5.3.9. Other Species 5.4. Y-o-Y Growth Trend Analysis By Species, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Species, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034 6.3.1. Academic & Research Institutions 6.3.2. Pharmaceutical Companies 6.3.3. Biotechnology Companies 6.3.4. Contract Research Organizations (CROs) 6.3.5. Other End Users 6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2024 to 2034 7.3.1. Basic and Applied Research 7.3.2. Drug Discovery/Development 7.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Species 9.2.3. By End User 9.2.4. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Species 9.3.3. By End User 9.3.4. By Application 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Species 10.2.3. By End User 10.2.4. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Species 10.3.3. By End User 10.3.4. By Application 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Species 11.2.3. By End User 11.2.4. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Species 11.3.3. By End User 11.3.4. By Application 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Species 12.2.3. By End User 12.2.4. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Species 12.3.3. By End User 12.3.4. By Application 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Species 13.2.3. By End User 13.2.4. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Species 13.3.3. By End User 13.3.4. By Application 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Species 14.2.3. By End User 14.2.4. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Species 14.3.3. By End User 14.3.4. By Application 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Species 15.2.3. By End User 15.2.4. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Species 15.3.3. By End User 15.3.4. By Application 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Species 16.1.2.2. By End User 16.1.2.3. By Application 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Species 16.2.2.2. By End User 16.2.2.3. By Application 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Species 16.3.2.2. By End User 16.3.2.3. By Application 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Species 16.4.2.2. By End User 16.4.2.3. By Application 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Species 16.5.2.2. By End User 16.5.2.3. By Application 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Species 16.6.2.2. By End User 16.6.2.3. By Application 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Species 16.7.2.2. By End User 16.7.2.3. By Application 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Species 16.8.2.2. By End User 16.8.2.3. By Application 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Species 16.9.2.2. By End User 16.9.2.3. By Application 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Species 16.10.2.2. By End User 16.10.2.3. By Application 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Species 16.11.2.2. By End User 16.11.2.3. By Application 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Species 16.12.2.2. By End User 16.12.2.3. By Application 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Species 16.13.2.2. By End User 16.13.2.3. By Application 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Species 16.14.2.2. By End User 16.14.2.3. By Application 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Species 16.15.2.2. By End User 16.15.2.3. By Application 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Species 16.16.2.2. By End User 16.16.2.3. By Application 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Species 16.17.2.2. By End User 16.17.2.3. By Application 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Species 16.18.2.2. By End User 16.18.2.3. By Application 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Species 16.19.2.2. By End User 16.19.2.3. By Application 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Species 16.20.2.2. By End User 16.20.2.3. By Application 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Species 16.21.2.2. By End User 16.21.2.3. By Application 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Species 16.22.2.2. By End User 16.22.2.3. By Application 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Species 16.23.2.2. By End User 16.23.2.3. By Application 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Species 17.3.3. By End User 17.3.4. By Application 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Charles River Laboratories International, Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Horizon Discovery Group plc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. The Jackson Laboratory 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Taconic Biosciences, Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Genoway SA 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Eurofins Scientific SE 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Crown Bioscience, Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Envigo CRS SA 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Transposagen Biopharmaceuticals, Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Animal Model Market
